# Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma

> **NCT00715793** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hussein Tawbi** · enrollment: 39 (actual)

## Conditions studied

- Malignant Melanoma

## Interventions

- **DRUG:** Decitabine
- **DRUG:** Temozolomide
- **PROCEDURE:** biopsy

## Key facts

- **NCT ID:** NCT00715793
- **Lead sponsor:** Hussein Tawbi
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2015-05
- **Final completion:** 2015-08
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2017-10-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00715793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00715793, "Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00715793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*